We examined the methylation level of twelve CpG sites a priori located in the promoter region of the bace-1 gene in cortical samples from 740 donors, of which 235 had no cognitive impairment (NCI), 175 had mild cognitive impairment (MCI) and 311 had AD. The gene discussed is BACE1; the disease is Alzheimer disease.